Patients were randomized 1:1 to receive tozorakimab 600 mg or placebo s.c. Q4W. In an exploratory sub-study, mucus plugging was assessed in lung segments by CT imaging at baseline and week 28, in ...

Patients (18–75 years old) were randomized 1:1 to tezepelumab 210 mg or placebo subcutaneously every 4 weeks for at least 28 weeks. Mucus plugging was scored at baseline and end of treatment in 18 ...